Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 25, 2018

Jun Shi v. Ampio Pharmaceuticals, Inc. et al

Track this case

Case Number:

2:18-cv-07476

Court:

California Central

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

R. Gary Klausner

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 27, 2018

    Deficient Drug Trial Caused Stock Drop, Ampio Investor Says

    Ampio Pharmaceuticals Inc. misled investors into believing that its arthritis treatment was going to be approved by the U.S. Food and Drug Administration, causing shares to drop when the company disclosed that the clinical trial had not been sufficient, according to a proposed class action in California federal court.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login